Liberta Partners has acquired a majority stake in forteq Healthcare, a Swiss-based MedTech company, aiming to accelerate its growth and expand its service offerings in response to rising demand.
Target Company Information
Liberta Partners has announced the acquisition of a majority stake in forteq Nidau AG, known as forteq Healthcare, a MedTech company headquartered in Nidau, Switzerland. The company specializes in the development and manufacturing of medical technology devices, primarily serving the pharmaceutical and laboratory sectors. The acquisition, part of a carve-out from the Swiss forteq Group, allows forteq Healthcare to continue operating from its established location in Nidau.
forteq Healthcare develops and produces complex medical devices that require high precision and expert manufacturing capabilities within controlled environments. Their core competencies encompass comprehensive client solutions, including research and development (R&D), manufacturing, and packaging, while adhering to the stringent quality standards demanded by the pharmaceutical and laboratory industries. The company currently produces approximately 35 million medical devices annually and employs around 100 staff at its Nidau headquarters.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Switzerland
Switzerland boasts a robust MedTech sector, known for its innovation and strong regulatory framework. The country is home to numerous leading multinational corporations and niche players that contribute sign
Similar Deals
KKA Partners → BLACKROLL
2025
Verium-Investoren → Zünd Präzisionsoptik und der Optivac
Liberta Partners
invested in
forteq Nidau AG
in 2023
in a Management Buyout / Buy-In (MBO) deal